Scientific Advisors

Renowned doctors in oncology research

Arnold Baskies, MD Director

Dr. Baskies, former Chairman of the national Board of Directors of the American Cancer Society, is a fellowship trained surgical oncologist with special interests in breast cancer, thyroid cancer, and melanoma. He received his Bachelor of Arts degree summa cum laude and was a member of Phi Beta Kappa at ...

Read More

Michael Shepard, Ph.D.

Dr. Shepard was a recipient of the 2019 Lasker-DeBakey Clinical Medical Research Award in recognition of his research work in improving patient lives in the field of oncology.  He also received the Warren Alpert Prize, an annual award granted by The Warren Alpert Foundation, for his pioneering research in the ...

Read More

Dmitry Gabrilovich, MD, Ph.D.

Dmitry Gabrilovich, MD, Ph.D., is currently a research and Christopher M. Davis professor at The Wistar Institute in Philadelphia. His laboratory at Wistar focuses on methods by which tumors are able to suppress the immune system and how to develop new immune therapies to combat this ability. He is one ...

Read More

Jose Conejo-Garcia, MD, Ph.D.

Dr. Conejo-Garcia completed his medical degree at the University of Zaragoza, in Spain. After a residency in Clinical Chemistry, he completed his PhD in Molecular Medicine from the University of Alcala, also in Spain, in 1998. He completed post doctorate training in pancreatic cancer at the University of Bern, Switzerland, ...

Read More

Marco Davila, MD, Ph.D.

Dr. Marco Davila is a medical oncologist in the Department of Blood and Marrow Transplantation. His clinical focus is utilizing cell therapies to treat patients with hematologic malignancies. He obtained his MD and PhD degrees at the Duke University School of Medicine and trained in medicine and medical oncology at ...

Read More

Daniel Abate-Daga, Ph.D.

Dr. Abate­‐Daga completed his undergraduate studies in clinical biochemistry at the Universidad Nacional de Córdoba (Argentina), and his PhD in Health and Life Sciences at the Pompeu Fabra University and Centre for Genomic Regulation (Barcelona, Spain). He completed post doctorate training in cancer immunotherapy and gene therapy, under the mentorship ...

Read More

Linda Kelley, Ph.D.

Dr. Linda Kelley is a Senior Member and Director of the Cell Therapy facility at Moffitt Cancer Center.  Previously she was the head of the Cell Therapy facility at Dana Farber Cancer Institute at Harvard.  As director of the Cell Therapy Facility at Moffitt Cancer Center, Dr. Kelley is responsible ...

Read More

Ian Frazer, MD

Dr. Ian Frazer is a professor at the University of Queensland where he leads a research team working at the Translational Research Institute (TRI) in Brisbane, Australia on the immunobiology of epithelial cancers. Additionally, he currently serves as the President of the Australian Academy of Health and Medical Sciences, and ...

Read More

Emanuele Ostuni, Ph.D.

Dr. Ostuni is Head of Europe for Cell and Gene Therapies at Novartis Oncology, where he oversees all commercialization aspects of the division's portfolio in Europe, including Kymriah, the first FDA-approved CAR-T cell therapy.  Dr. Ostuni has been with Novartis since 2012 in various executive roles.  Previously he held positions ...

Read More

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference


Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program


Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference


Cancer Fact: Cancer risk factors include tobacco use, obesity, age, exposure to sunlight, exposure to radiation, alcohol consumption, diet, and chronic inflammation.